The State Department’s global health chief is on the lookout for “the next lenacapavir” — but this time, he hopes that will mean an innovation for tuberculosis instead of HIV.
“We’re thinking, alongside these [memorandums of understanding] that we’re signing with governments, how do we set aside [money] for innovations?” said Jeffrey Graham, the senior bureau official for the State Department’s Bureau of Global Health Security and Diplomacy, speaking at a tuberculosis-focused briefing for congressional staffers on Tuesday.
“A scalable, innovative invention that not only can change the course of an epidemic, but also for us, as stewards of taxpayer dollars in the U.S., that can help us move away from being forever donors,” he added.